(CRC) California Resources - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US13057Q3056
Stock: Oil, Natural Gas, Carbon Capture, Power Generation
Total Rating 63
Risk 74
Buy Signal 0.75
| Risk 5d forecast | |
|---|---|
| Volatility | 37.8% |
| Relative Tail Risk | -6.27% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.31 |
| Alpha | 47.25 |
| Character TTM | |
|---|---|
| Beta | 1.202 |
| Beta Downside | 1.738 |
| Drawdowns 3y | |
|---|---|
| Max DD | 44.75% |
| CAGR/Max DD | 0.46 |
EPS (Earnings per Share)
Revenue
Description: CRC California Resources March 05, 2026
California Resources Corp (CRC) is an independent energy and carbon management company based in Long Beach, California, incorporated in 2014.
The company operates in two segments: Oil and Natural Gas, and Carbon Management. The Oil and Natural Gas segment explores, develops, and produces crude oil, oil condensate, natural gas liquids, and natural gas for California refineries, marketers, and other purchasers. This business model is common for upstream energy companies.
The Carbon Management segment, branded as Carbon TerraVault, focuses on building, installing, operating, and maintaining CO2 capture equipment, transportation assets, and storage facilities. Carbon capture and storage is an emerging sector within the energy industry.
CRC also owns and operates power generation facilities, including smaller gas-fired power plants, to support its oil and natural gas operations.
Further analysis of CRCs financials and market position can provide a deeper understanding.
Headlines to watch out for
- Crude oil and natural gas prices dictate revenue
- California environmental regulations impact operating costs
- Carbon capture project development drives future growth
- State energy policies influence power generation segment
- Global economic slowdown reduces energy demand
Piotroski VR‑10 (Strict, 0-10) 8.5
| Net Income: 363.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 4.77 > 1.0 |
| NWC/Revenue: -3.22% < 20% (prev 1.49%; Δ -4.71% < -1%) |
| CFO/TA 0.13 > 3% & CFO 864.0m > Net Income 363.0m |
| Net Debt (1.12b) to EBITDA (1.34b): 0.84 < 3 |
| Current Ratio: 0.89 > 1.5 & < 3 |
| Outstanding Shares: last quarter (87.4m) vs 12m ago -5.21% < -2% |
| Gross Margin: 37.40% > 18% (prev 0.41%; Δ 3699 % > 0.5%) |
| Asset Turnover: 49.74% > 50% (prev 41.44%; Δ 8.29% > 0%) |
| Interest Coverage Ratio: 6.75 > 6 (EBITDA TTM 1.34b / Interest Expense TTM 106.0m) |
Altman Z'' 2.15
| A: -0.02 (Total Current Assets 938.0m - Total Current Liabilities 1.05b) / Total Assets 6.84b |
| B: 0.28 (Retained Earnings 1.91b / Total Assets 6.84b) |
| C: 0.10 (EBIT TTM 715.0m / Avg Total Assets 6.99b) |
| D: 0.63 (Book Value of Equity 1.99b / Total Liabilities 3.17b) |
| Altman-Z'' Score: 2.15 = BBB |
Beneish M -3.63
| DSRI: 0.83 (Receivables 455.0m/467.0m, Revenue 3.48b/2.96b) |
| GMI: 1.09 (GM 37.40% / 40.58%) |
| AQI: 0.0 (AQ_t 0.0 / AQ_t-1 0.05) |
| SGI: 1.18 (Revenue 3.48b / 2.96b) |
| TATA: -0.07 (NI 363.0m - CFO 864.0m) / TA 6.84b) |
| Beneish M-Score: -3.63 (Cap -4..+1) = AAA |
What is the price of CRC shares?
As of March 10, 2026, the stock is trading at USD 64.74 with a total of 1,334,554 shares traded.
Over the past week, the price has changed by +5.25%, over one month by +16.00%, over three months by +36.99% and over the past year by +59.91%.
Over the past week, the price has changed by +5.25%, over one month by +16.00%, over three months by +36.99% and over the past year by +59.91%.
Is CRC a buy, sell or hold?
California Resources has received a consensus analysts rating of 4.42.
Therefore, it is recommended to buy CRC.
- StrongBuy: 7
- Buy: 3
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CRC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 66.7 | 3% |
| Analysts Target Price | 66.7 | 3% |
CRC Fundamental Data Overview March 07, 2026
P/E Trailing = 15.2398
P/E Forward = 36.1011
P/S = 1.6679
P/B = 1.6096
P/EG = 8.5455
Revenue TTM = 3.48b USD
EBIT TTM = 715.0m USD
EBITDA TTM = 1.34b USD
Long Term Debt = 889.0m USD (from longTermDebt, two quarters ago)
Short Term Debt = 15.0m USD (from shortTermDebt, last quarter)
Debt = 1.36b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.12b USD (from netDebt column, last quarter)
Enterprise Value = 6.80b USD (5.68b + Debt 1.36b - CCE 235.0m)
Interest Coverage Ratio = 6.75 (Ebit TTM 715.0m / Interest Expense TTM 106.0m)
EV/FCF = 10.27x (Enterprise Value 6.80b / FCF TTM 662.0m)
FCF Yield = 9.74% (FCF TTM 662.0m / Enterprise Value 6.80b)
FCF Margin = 19.04% (FCF TTM 662.0m / Revenue TTM 3.48b)
Net Margin = 10.44% (Net Income TTM 363.0m / Revenue TTM 3.48b)
Gross Margin = 37.40% ((Revenue TTM 3.48b - Cost of Revenue TTM 2.18b) / Revenue TTM)
Gross Margin QoQ = 35.48% (prev 38.38%)
Tobins Q-Ratio = 0.99 (Enterprise Value 6.80b / Total Assets 6.84b)
Interest Expense / Debt = 2.13% (Interest Expense 29.0m / Debt 1.36b)
Taxrate = 47.83% (11.0m / 23.0m)
NOPAT = 373.0m (EBIT 715.0m * (1 - 47.83%))
Current Ratio = 0.89 (Total Current Assets 938.0m / Total Current Liabilities 1.05b)
Debt / Equity = 0.37 (Debt 1.36b / totalStockholderEquity, last quarter 3.67b)
Debt / EBITDA = 0.84 (Net Debt 1.12b / EBITDA 1.34b)
Debt / FCF = 1.70 (Net Debt 1.12b / FCF TTM 662.0m)
Total Stockholder Equity = 3.51b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.19% (Net Income 363.0m / Total Assets 6.84b)
RoE = 10.34% (Net Income TTM 363.0m / Total Stockholder Equity 3.51b)
RoCE = 16.25% (EBIT 715.0m / Capital Employed (Equity 3.51b + L.T.Debt 889.0m))
RoIC = 8.35% (NOPAT 373.0m / Invested Capital 4.47b)
WACC = 8.57% (E(5.68b)/V(7.03b) * Re(10.35%) + D(1.36b)/V(7.03b) * Rd(2.13%) * (1-Tc(0.48)))
Discount Rate = 10.35% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 11.15%
[DCF] Terminal Value 79.44% ; FCFF base≈537.2m ; Y1≈662.7m ; Y5≈1.13b
[DCF] Fair Price = 179.0 (EV 17.11b - Net Debt 1.12b = Equity 15.98b / Shares 89.3m; r=8.57% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -18.46 | EPS CAGR: -20.86% | SUE: -0.31 | # QB: 0
Revenue Correlation: 15.69 | Revenue CAGR: 5.40% | SUE: 2.00 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.43 | Chg7d=+0.194 | Chg30d=+0.189 | Revisions Net=-7 | Analysts=8
EPS current Year (2026-12-31): EPS=1.94 | Chg7d=+0.383 | Chg30d=+0.161 | Revisions Net=-9 | Growth EPS=-52.8% | Growth Revenue=-2.8%
EPS next Year (2027-12-31): EPS=2.74 | Chg7d=-0.162 | Chg30d=-0.248 | Revisions Net=-6 | Growth EPS=+41.3% | Growth Revenue=+2.8%
[Analyst] Revisions Ratio: -0.78 (1 Up / 8 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.8% (Discount Rate 10.3% - Earnings Yield 6.6%)
[Growth] Growth Spread = -13.5% (Analyst -9.7% - Implied 3.8%)
P/E Forward = 36.1011
P/S = 1.6679
P/B = 1.6096
P/EG = 8.5455
Revenue TTM = 3.48b USD
EBIT TTM = 715.0m USD
EBITDA TTM = 1.34b USD
Long Term Debt = 889.0m USD (from longTermDebt, two quarters ago)
Short Term Debt = 15.0m USD (from shortTermDebt, last quarter)
Debt = 1.36b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.12b USD (from netDebt column, last quarter)
Enterprise Value = 6.80b USD (5.68b + Debt 1.36b - CCE 235.0m)
Interest Coverage Ratio = 6.75 (Ebit TTM 715.0m / Interest Expense TTM 106.0m)
EV/FCF = 10.27x (Enterprise Value 6.80b / FCF TTM 662.0m)
FCF Yield = 9.74% (FCF TTM 662.0m / Enterprise Value 6.80b)
FCF Margin = 19.04% (FCF TTM 662.0m / Revenue TTM 3.48b)
Net Margin = 10.44% (Net Income TTM 363.0m / Revenue TTM 3.48b)
Gross Margin = 37.40% ((Revenue TTM 3.48b - Cost of Revenue TTM 2.18b) / Revenue TTM)
Gross Margin QoQ = 35.48% (prev 38.38%)
Tobins Q-Ratio = 0.99 (Enterprise Value 6.80b / Total Assets 6.84b)
Interest Expense / Debt = 2.13% (Interest Expense 29.0m / Debt 1.36b)
Taxrate = 47.83% (11.0m / 23.0m)
NOPAT = 373.0m (EBIT 715.0m * (1 - 47.83%))
Current Ratio = 0.89 (Total Current Assets 938.0m / Total Current Liabilities 1.05b)
Debt / Equity = 0.37 (Debt 1.36b / totalStockholderEquity, last quarter 3.67b)
Debt / EBITDA = 0.84 (Net Debt 1.12b / EBITDA 1.34b)
Debt / FCF = 1.70 (Net Debt 1.12b / FCF TTM 662.0m)
Total Stockholder Equity = 3.51b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.19% (Net Income 363.0m / Total Assets 6.84b)
RoE = 10.34% (Net Income TTM 363.0m / Total Stockholder Equity 3.51b)
RoCE = 16.25% (EBIT 715.0m / Capital Employed (Equity 3.51b + L.T.Debt 889.0m))
RoIC = 8.35% (NOPAT 373.0m / Invested Capital 4.47b)
WACC = 8.57% (E(5.68b)/V(7.03b) * Re(10.35%) + D(1.36b)/V(7.03b) * Rd(2.13%) * (1-Tc(0.48)))
Discount Rate = 10.35% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 11.15%
[DCF] Terminal Value 79.44% ; FCFF base≈537.2m ; Y1≈662.7m ; Y5≈1.13b
[DCF] Fair Price = 179.0 (EV 17.11b - Net Debt 1.12b = Equity 15.98b / Shares 89.3m; r=8.57% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -18.46 | EPS CAGR: -20.86% | SUE: -0.31 | # QB: 0
Revenue Correlation: 15.69 | Revenue CAGR: 5.40% | SUE: 2.00 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.43 | Chg7d=+0.194 | Chg30d=+0.189 | Revisions Net=-7 | Analysts=8
EPS current Year (2026-12-31): EPS=1.94 | Chg7d=+0.383 | Chg30d=+0.161 | Revisions Net=-9 | Growth EPS=-52.8% | Growth Revenue=-2.8%
EPS next Year (2027-12-31): EPS=2.74 | Chg7d=-0.162 | Chg30d=-0.248 | Revisions Net=-6 | Growth EPS=+41.3% | Growth Revenue=+2.8%
[Analyst] Revisions Ratio: -0.78 (1 Up / 8 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.8% (Discount Rate 10.3% - Earnings Yield 6.6%)
[Growth] Growth Spread = -13.5% (Analyst -9.7% - Implied 3.8%)